Vanguard Capital Management’s Kiora Pharmaceuticals KPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding KPRX
Vanguard Capital Management's KPRX Position: Q3 2026 in Review
Vanguard Capital Management increased its Kiora Pharmaceuticals (KPRX) stake by 11% in Q3 2026, buying an estimated $5.46K and bringing the position to 21,974 shares worth $56.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3896.
Vanguard Capital Management first reported a position in KPRX in Q1 2026 and has held it in 3 quarters since. 12 funds tracked by Wall St. Rank hold KPRX as of Q3 2026.
- Vanguard Capital Management held 21,974 shares of Kiora Pharmaceuticals worth $56.3K as of Q3 2026.
- Vanguard Capital Management bought 2,113 Kiora Pharmaceuticals shares in Q3 2026, an estimated $5.46K.
- Kiora Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3896 holding.
- Vanguard Capital Management first reported a position in Kiora Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 12 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.